Literature DB >> 22778283

A rare complication with a single dose of alendronate.

Srinivasa Munigoti1, Ricky Frazer, Alan Rees, Guy Blackshaw, Gareth Thomas, Aled Roberts.   

Abstract

The authors present a case of an 84-year-old patient who presented to the emergency department with sudden onset abdominal pain radiating to the neck. The patient's medication included warfarin, and alendronate, which was started by the general practitioner 2 days prior to presentation. Initial systemic examination and investigations, including chest x-ray, were unremarkable. Within 24 h of presentation the patient developed bilateral pneumonia with effusions. Due to continued clinical deterioration over the next 48 h, a CT thorax was performed that showed evidence of large oesophageal perforation with mediastinitis and gas in the mediastinum. The patient was treated with an expandable metal stent, bilateral chest drains, broad spectrum antibiotics, antifungals and total parenteral nutrition. Over a period of 8 weeks the patient made an excellent recovery. This rare case illustrates the importance of vigilance for the life-threatening complication of oesophageal perforation with alendronate treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22778283      PMCID: PMC3027761          DOI: 10.1136/bcr.02.2010.2738

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

1.  Severe oral ulcerations induced by alendronate.

Authors:  N Demerjian; G Bolla; A Spreux
Journal:  Clin Rheumatol       Date:  1999       Impact factor: 2.980

2.  Fatal esophageal perforation with alendronate.

Authors:  G Famularo; C De Simone
Journal:  Am J Gastroenterol       Date:  2001-11       Impact factor: 10.864

Review 3.  Esophagitis associated with the use of alendronate.

Authors:  P C de Groen; D F Lubbe; L J Hirsch; A Daifotis; W Stephenson; D Freedholm; S Pryor-Tillotson; M J Seleznick; H Pinkas; K K Wang
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

4.  Esophageal irritation due to alendronate sodium tablets: possible mechanisms.

Authors:  C P Peter; L K Handt; S M Smith
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

  4 in total
  1 in total

Review 1.  Alendronate prevents glucocorticoid-induced osteoporosis in patients with rheumatic diseases: A meta-analysis.

Authors:  Shun-Li Kan; Zhi-Fang Yuan; Yan Li; Jie Ai; Hong Xu; Jing-Cheng Sun; Shi-Qing Feng
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.